Celularity Inc. Class A Common Stock (CELU) stock analysis and AI prediction
The company facts of Celularity Inc. Class A Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Celularity Inc. Class A Common Stock
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $22.2 million
- Size
- Micro cap
- Employees
- 115
- Headquarters
- FLORHAM PARK, NJ
- Listed since
- July 19, 2021
- Website
- celularity.com
More Healthcare stocks
Other micro cap stocks
Keep going
CELU questions
What is the AI prediction for CELU stock?
Each market day our model rates Celularity Inc. Class A Common Stock (CELU) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the CELU prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for CELU?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see CELU options?
The CELU options page opens its calls and puts, with price, volume, implied volatility and the Greeks.